Enveric Biosciences, Inc.

NasdaqCM:ENVB Voorraadrapport

Marktkapitalisatie: US$4.4m

Enveric Biosciences Beheer

Beheer criteriumcontroles 3/4

Enveric Biosciences' CEO is Joseph Tucker, appointed in Sep 2021, has a tenure of 3.17 years. total yearly compensation is $577.07K, comprised of 78.1% salary and 21.9% bonuses, including company stock and options. directly owns 0.33% of the company’s shares, worth $14.39K. The average tenure of the management team and the board of directors is 3.2 years and 2.3 years respectively.

Belangrijke informatie

Joseph Tucker

Algemeen directeur

US$577.1k

Totale compensatie

Percentage CEO-salaris78.1%
Dienstverband CEO3.2yrs
Eigendom CEO0.3%
Management gemiddelde ambtstermijn3.2yrs
Gemiddelde ambtstermijn bestuur2.3yrs

Recente managementupdates

Recent updates

An Intrinsic Calculation For Enveric Biosciences, Inc. (NASDAQ:ENVB) Suggests It's 40% Undervalued

Jul 02
An Intrinsic Calculation For Enveric Biosciences, Inc. (NASDAQ:ENVB) Suggests It's 40% Undervalued

Enveric Biosciences to raise $8M in stock offering for corporate use

Jul 25

Enveric Biosciences Goes Psychedelic With MagicMed Acquisition

May 31

Enveric Biosciences announces $10M registered direct offering

Jan 12

Analyse CEO-vergoeding

Hoe is Joseph Tucker's beloning veranderd ten opzichte van Enveric Biosciences's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

-US$11m

Mar 31 2024n/an/a

-US$15m

Dec 31 2023US$577kUS$451k

-US$17m

Sep 30 2023n/an/a

-US$23m

Jun 30 2023n/an/a

-US$23m

Mar 31 2023n/an/a

-US$19m

Dec 31 2022US$826kUS$362k

-US$19m

Sep 30 2022n/an/a

-US$52m

Jun 30 2022n/an/a

-US$52m

Mar 31 2022n/an/a

-US$50m

Dec 31 2021US$3mUS$92k

-US$49m

Compensatie versus markt: Joseph's total compensation ($USD577.07K) is about average for companies of similar size in the US market ($USD655.65K).

Compensatie versus inkomsten: Joseph's compensation has been consistent with company performance over the past year.


CEO

Joseph Tucker (55 yo)

3.2yrs

Tenure

US$577,065

Compensatie

Dr. Joseph Tucker, Ph D., has been a Director of Enveric Biosciences, Inc. since September 16, 2021. Dr. Tucker has been the Chief Executive Officer of Enveric Biosciences, Inc. since September 16, 2021.D...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Joseph Tucker
CEO & Director3.2yrsUS$577.07k0.33%
$ 14.4k
Kevin Coveney
Chief Financial Officer1.7yrsUS$435.31k0.074%
$ 3.3k
Peter Facchini
Chief Innovation Officer3.2yrsUS$282.06k0.22%
$ 9.7k

3.2yrs

Gemiddelde duur

60yo

Gemiddelde leeftijd

Ervaren management: ENVB's management team is considered experienced (3.2 years average tenure).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Joseph Tucker
CEO & Director3.2yrsUS$577.07k0.33%
$ 14.4k
Michael Webb
Independent Chairman of the Board2.4yrsUS$175.00k0.54%
$ 23.5k
Sheila DeWitt
Independent Directorless than a yeargeen gegevens0.31%
$ 13.7k
Stephen Stahl
Member of Scientific Advisory Board2.3yrsgeen gegevensgeen gegevens
Frank Pasqualone
Independent Director2.3yrsUS$57.50k0.55%
$ 24.0k
Maurizio Fava
Chairman of Scientific Advisory Board2.3yrsgeen gegevensgeen gegevens
Michael Liebowitz
Member of Scientific Advisory Board2.3yrsgeen gegevensgeen gegevens
John Krystal
Member of Scientific Advisory Board2.3yrsgeen gegevensgeen gegevens
Marcus Schabacker
Independent Non-Employee Director3.9yrsUS$52.00k0.54%
$ 23.6k
George Kegler
Independent Non-Employee Director3.9yrsUS$59.00k0.54%
$ 23.6k

2.3yrs

Gemiddelde duur

64yo

Gemiddelde leeftijd

Ervaren bestuur: ENVB's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.